Pancreatic cancer
Survival depends on many factors. No one can tell you exactly how long you will live.
Below are general statistics based on large groups of people. Remember, they can’t tell you what will happen in your individual case.
The terms 1 year survival, 3 year survival and 5 year survival do not mean that you will only live for 1, 3 or 5 years.
Statisticians and researchers collect information. They watch what happens to people with cancer in the years after their diagnosis. 5 years is a common time point to measure survival. But some people live longer than this.
5 year survival is the number of people who have not died from their cancer within 5 years after diagnosis.
There are different types of pancreatic cancer. Most pancreatic cancers are the exocrine type. This means they start in cells that produce a juice that helps us digest our food (digestive juice).
Cancer can also start in cells that make insulin and hormones. Doctors call these pancreatic neuroendocrine cancers.
This survival by stage information comes from a large study looking at the cancer registries of 7 countries. Cancer registries collect information about a person’s cancer directly from hospitals and healthcare professionals.
The information about survival by stage is for people diagnosed with pancreatic cancer between 2012 and 2014.
This study included the UK. But the researchers excluded Scotland as there was missing information. So the following is based on England, Wales and Northern Ireland.
The statistics are split into 3 stage groups – localised, regional and distant cancers. In the UK, your doctor might not use these terms. Instead, they might describe the cancer as a number stage (stage 1 to 4). The following descriptions are a guide to help you understand whether the cancer is localised, regional or distant.
This isn’t always straight forward and will depend on your individual situation. Talk to your specialist if you are unsure which group you are in.
Localised cancer means the cancer has not spread beyond the pancreas.
Regional cancer means the cancer has spread to nearby .
Distant cancer means the cancer has spread to another part of your body.
Read more about the stages and types of pancreatic cancer
Almost 55 out of 100 people (almost 55%) survive their cancer for 1 year or more after diagnosis.
More than 25 out of 100 people (more than 25%) survive their cancer for 3 years or more after diagnosis.
Around 50 out of 100 people (around 50%) survive their cancer for 1 year or more after diagnosis.
Around 15 out of 100 people (around 15%) survive their cancer for 3 years or more after diagnosis.
Around 10 out of 100 people (around 10%) survive their cancer for 1 year or more after diagnosis.
Only 1 out of 100 people (1%) survive their cancer for 3 years or more after diagnosis.
The UK survival statistics come from England and Wales. Scotland and Northern Ireland have a similar population and health care system. So we can apply these survival statistics to the whole of the UK.
Generally for adults with pancreatic cancer in the UK:
25 out of every 100 (25%) survive their cancer for 1 year or more
more than 5 out of every 100 (more than 5%) survive their cancer for 5 years or more
around 5 out of every 100 (around 5%) survive their cancer for 10 years or more
One reason for the poor outlook for pancreatic cancer is that it is often diagnosed late. The cancer is very often quite advanced and surgery to remove it isn’t possible.
Pancreatic neuroendocrine cancers are an uncommon type of pancreatic cancer.
Read more about pancreatic neuroendocrine cancers
The following statistics are for survival for the different stages of all types of pancreatic neuroendocrine cancer. We have statistics for:
all types of pancreatic neuroendocrine tumours (NETs) - this includes insulinoma, gastrinoma, VIPoma, glucagonoma, somatostatinoma and non functioning pancreatic NETs
pancreatic neuroendocrine carcinomas (NECs)
More than 85 out of 100 people (more than 85%) survive for 5 years or more.
85 out of 100 people (85%) survive for 5 years or more.
Around 70 out of 100 people (around 70%) survive for 5 years or more.
Around 25% out of 100 people (around 25%) survive for 5 years or more.
Around 70 out of 100 people (around 70%) survive for 5 years or more.
Around 60 out of 100 people (around 60%) survive for 5 years or more.
Almost 35 out of 100 people (almost 35%) survive for 5 years or more.
Around 10 out of 100 people (around 10%) survive for 5 years or more.
Your outlook depends on the stage of the cancer when it was diagnosed. This means how big it is and whether it has spread.
The type of pancreatic cancer and grade of the cancer cells can also affect your likely survival. Grade means how abnormal the cells look under the microscope.
Your general health and fitness also affect survival. This is because the better your health, the more likely you may be able to cope with the cancer and your treatment.
For more in-depth information about survival and other statistics for pancreatic cancer, go to our Cancer Statistics section.
Last reviewed: 25 Jun 2026
Next review due: 25 Jun 2029
Stage means the size of the cancer and whether it has spread. Type is the type of cell it started from. Grade means how abnormal the cells look. Knowing this information helps doctors recommend the best treatment.
Most people are diagnosed with pancreatic cancer after they become unwell and go to A&E. Others start by seeing their GP. Find out what to expect when you see your GP and any tests you might have.
Your treatment depends on the position of the cancer in the pancreas, how big it is, the type of pancreatic cancer, whether it has spread, if they can remove it with surgery and your general health.
There is practical and emotional support available to help you cope with a diagnosis of pancreatic cancer, and life during and after treatment.
Pancreatic cancer starts in the pancreas. This is the gland that produces digestive juices and hormones such as insulin. Find out more including treatments, survival and coping with pancreatic cancer.
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
